BRCA2 and ovarian carcinoma: Consistent with this, loss of BRCA2 occurs in tumors and is thought to promote tumorigenesis, while BRCA2 heterozygous germline mutations increase susceptibility to breast and ovarian cancer, as well as other cancers11–13.